I am neither for or against the argument of naked
Post# of 72440
Unfortunately the OTC market is filled with greed and has always been considered HIGH risk investment.
This ALL being said leads to the cliche, high risk, high reward. The tactics these MMs and shorts use will cause this stock to EXPLODE on great news or have a significantly higher acquisition price per share then current pps. Idiots on the other board will say “why would big Pharma pay $20 per share for a $.50 per share company?” Biotech is like the American dollar, it’s not based off real revenue, it’s based off the sanctity of the company and other companies will pay to acquire based on the sanctity of the science which is real. Big Pharma tends to start as little Pharma therefore they know the tactics that have been used to depress share price and they know share price has NOTHING to do with the value of this company.
CUSIP change is a way to combat Naked Short when it’s a concerted effort like the Mako attack. I feel minimal naked shorting is occurring now only for the MMs to trade securities to keep themselves alive to fulfill shares when called upon. I don’t believe it’s being done to hurt share price because that takes much more of an effort and IPIX is no longer a good target.
Here is one example of a CUSIP change to combat naked shorting and MMs manipulation.
http://m.marketwired.com/press-release/chimer...712244.htm